Routine use of percutaneous femoral cannulation in minimally invasive cardiac surgery
Authors:
- 24 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 63 (3)
Abstract
OBJECTIVES: Large series of percutaneous femoral access for extracorporeal circulation in minimally invasive cardiac surgery (MICS) are scarcely reported.METHODS: This is a single-centre study describing the use of percutaneous femoral access in patients undergoing MICS via minithoracotomy. Femoral artery closure was performed with a plug-based closure device. To reduce the risk for vascular complications, intraoperative ultrasound assessment of correct deployment of the arterial closure device was done during the later period of the study.RESULTS: During a 5-year period, 650 patients underwent percutaneous femoral cannulation and decannulation with device closure of the femoral artery puncture. Two hundred and seven patients (31.8%) were operated in the early phase of the experience (August 2017–August 2019), without the use of intraoperative ultrasound assessment of closure device deployment. During the later period of our experience (August 2019–September 2022), 443 patients (68.2%) were operated, of whom all underwent intraoperative ultrasound assessment of closure device deployment. Of the patients operated without intraoperative ultrasound assessment, 6 patients (2.9%) experienced vascular complications compared with none of the patients in whom intraoperative ultrasound-assessment was used (P < 0.001). In total, 15 patients (2.3%) underwent conversion to surgical cutdown owing to incomplete haemostasis or femoral artery stenosis/occlusion and the mechanism was intravascular deployment of the closure device in all 15 cases.CONCLUSIONS: Percutaneous femoral access in MICS is safe and the need for surgical cutdown was infrequent. The risk for vascular complications is minimized with the use of intraoperative ultrasound assessment of the correct positioning of the vascular closure device.CLINICAL TRIAL REGISTRATION NUMBER: http://www.clinicaltrials.gov; Unique identifier: NCT05462769.Keywords
Funding Information
- Karolinska Institutet (2018-02009)
This publication has 14 references indexed in Scilit:
- Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTAThe American Journal of Cardiology, 2019
- Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlideEuroIntervention, 2019
- Impact of percutaneous femoral arteriotomy closure using the MANTATM device on vascular and bleeding complications after transcatheter aortic valve replacementCatheterization and Cardiovascular Interventions, 2018
- Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patientsJournal of Vascular Surgery, 2018
- Complications Associated With Femoral Cannulation During Minimally Invasive Cardiac SurgeryThe Annals of Thoracic Surgery, 2017
- Percutaneous cannulation for cardiopulmonary bypass in minimally invasive surgery is associated with reduced groin complicationsInteractive CardioVascular and Thoracic Surgery, 2017
- Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore AccessJACC: Cardiovascular Interventions, 2017
- The MANTA Vascular Closure DeviceJACC: Cardiovascular Interventions, 2016
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus documentThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Minimally Invasive versus Conventional Open Mitral Valve Surgery a Meta-Analysis and Systematic ReviewInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2011